NK Cell Function in HIV-1 Infection

被引:23
作者
De Maria, Andrea [1 ,2 ,3 ]
Moretta, Lorenzo [3 ,4 ,5 ]
机构
[1] Ist Nazl Ric Canc, Infect Dis Unit, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy
[3] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy
[4] Univ Genoa, Dept Expt Med, Genoa, Italy
[5] Ist Sci G Gaslini, Genoa, Italy
关键词
NK cell; HIV-1; natural cytotoxicity receptor; dendritic cells;
D O I
10.2174/157016208785861221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The parallel development of precise knowledge on NK cell receptors and on their function has considerably supported our understanding of the extension of their involvement during HIV-1 infection. The relevant reduction of NK cell function is dependent on well-described perturbations of their expression of specific receptors, leading not only to inhibition of their patrolling activity against invading pathogens, but also to alterations of their crosstalk with other cells of the immune system. With NK cell failure, boosted viral replication reduces immune surveillance towards opportunistic neoplasm and impaired control of adaptive responses prevails. NK cell function in human and animal models showing efficient control of disease progression may offer new insights in mechanisms underlying the protection from infectious disease.
引用
收藏
页码:433 / 440
页数:8
相关论文
共 102 条
[1]   Persistent abnormalities in peripheral blood dendritic cells and monocytes from HIV-1-positive patients after 1 year of antiretroviral therapy [J].
Almeida, M ;
Cordero, M ;
Almeida, J ;
Orfao, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (04) :405-415
[2]   Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection [J].
Alter, G ;
Teigen, N ;
T Davis, B ;
Addo, MM ;
Suscovich, TJ ;
Waring, MT ;
Streeck, H ;
Johnston, MN ;
Staller, KD ;
Zaman, MT ;
Yu, XG ;
Lichterfeld, M ;
Basgoz, N ;
Rosenberg, ES ;
Altfeld, M .
BLOOD, 2005, 106 (10) :3366-3369
[3]   Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes [J].
Alter, Galit ;
Martin, Maureen P. ;
Teigen, Nickolas ;
Carr, William H. ;
Suscovich, Todd J. ;
Schneidewind, Arne ;
Streeck, Hendrik ;
Waring, Michael ;
Meier, Angela ;
Brander, Christian ;
Lifson, Jeffrey D. ;
Allen, Todd M. ;
Carrington, Mary ;
Altfeld, Marcus .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (12) :3027-3036
[4]   Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells [J].
Alter, Galit ;
Suscovich, Todd J. ;
Teigen, Nickolas ;
Meier, Angela ;
Streeck, Hendrik ;
Brander, Christian ;
Altfeld, Marcus .
JOURNAL OF IMMUNOLOGY, 2007, 178 (12) :7658-7666
[5]   Virus-driven evolution of natural killer cell receptors [J].
Arase, H ;
Lanier, LL .
MICROBES AND INFECTION, 2002, 4 (15) :1505-1512
[6]   Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions [J].
Beignon, AS ;
McKenna, K ;
Skoberne, M ;
Manches, O ;
DaSilva, I ;
Kavanagh, DG ;
Larsson, M ;
Gorelick, RJ ;
Lifson, JD ;
Bhardwaj, N .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3265-3275
[7]   HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells [J].
Betts, Michael R. ;
Nason, Martha C. ;
West, Sadie M. ;
De Rosa, Stephen C. ;
Migueles, Stephen A. ;
Abraham, Jonathan ;
Lederman, Michael M. ;
Benito, Jose M. ;
Goepfert, Paul A. ;
Connors, Mark ;
Roederer, Mario ;
Koup, Richard A. .
BLOOD, 2006, 107 (12) :4781-4789
[8]   SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS [J].
BIRON, CA ;
BYRON, KS ;
SULLIVAN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) :1731-1735
[9]   T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy [J].
Blazevic, V ;
Sahgal, N ;
Kessler, HA ;
Landay, AL ;
Shearer, GM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (17) :1887-1893
[10]   Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule [J].
Bottino, C ;
Castriconi, R ;
Pende, D ;
Rivera, P ;
Nanni, M ;
Carnemolla, B ;
Cantoni, C ;
Grassi, J ;
Marcenaro, S ;
Reymond, N ;
Vitale, M ;
Moretta, L ;
Lopez, M ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) :557-567